Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1309 of 5804
-
New drug shows promise for Long-Term control of chronic hives
Disease control OngoingPhase 2, open-label, extension study to evaluate the long-term safety, clinical activity, and pharmacodynamics of briquilimab in participants previously enrolled in a Jasper sponsored CU clinical trial.
Phase: PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Internet therapy could ease OCD in kids with autism
Symptom relief Recruiting nowThe purpose of this trial is to evaluate the clinical efficacy, the cost-effectiveness and the effect durability of a therapist-guided, internet-delivered cognitive-behavior therapy intervention for obsessive-compulsive disorder (OCD) in children and adolescents with autism. A pr…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New drug tulisokibart tested for long-term safety in bowel disease patients
Disease control Recruiting nowResearchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). An extension study is a type of study where people who receiv…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New ligament could replace torn ACL without using your own tissue
Disease control ENROLLING_BY_INVITATIONA randomized, multicenter study comparing the safety and efficacy of CT-ACL001, a regenerative ligament, with standard treatment in anterior cruciate ligament reconstruction
Phase: NA • Sponsor: CoreTissue BioEngineering Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for millions of kids: easier treatment for a devastating parasitic disease
Disease control Recruiting nowThe proposed small-scale pilot studies are public health intervention studies implemented through established routine programs and services in the frame of the mass drug administration (MDA) campaigns in Côte d'Ivoire, Kenya and Uganda. In each country two most promising health i…
Sponsor: Peter Steinmann • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can an eczema drug stop the relentless itch of lichen simplex chronicus?
Symptom relief OngoingThis is a parallel, Phase 3, 2-arm study for treatment. The purpose of this study is to measure improvement in pruritus with dupilumab subcutaneous injections compared with placebo injections in male and female participants aged at least 18 years with LSC. Study details include:…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Vulvar cancer breakthrough: surgery tailored by virus and gene status
Disease control Recruiting nowVulvar cancer affects the external genitalia of women. This type of cancer is uncommon, arising mostly in older women and has been neglected in research and clinical trials. Over the recent years, investigators have learned that the most common type of vulvar cancer; vulvar squam…
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Real-world check for GORE TAMBE device in tough aortic aneurysms
Disease control OngoingThis study aims to confirm that the benefit-risk assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) remains positive in real-world use and to ensure the adequacy of the TAMBE Device training program.
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New program aims to boost muscle in cystic fibrosis patients on trikafta
Disease control Recruiting nowCystic fibrosis is an autosomal recessive inherited disease linked to various mutations in the gene coding for the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, with respiratory and digestive disorders conditioning the prognosis. Digestive damage may be res…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Nasal spray shows promise against suicidal thoughts – but who benefits most?
Knowledge-focused OngoingThis study is looking at how intranasal esketamine (a nasal spray) can help reduce suicidal thoughts in patients with severe depression who are experiencing suicidal thoughts. Suicidal depression is a type of depression where people have active thoughts of suicide, which can be h…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Blood patch may keep lungs sealed after cancer treatment
Symptom relief Recruiting nowThermal ablation is an established treatment for lung cancer. It involves insertion of a applicator under image guidance into a lung tumour and destroying it with radiofrequency, microwave or cryotherapy. One of the common side effects is pneumothorax, which is a leak of gas from…
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Pill vs. needle: can Lower-Dose blood thinners protect blood cancer patients from deadly clots?
Disease control Recruiting nowThis study investigates the efficacy and safety of direct oral anticoagulants (DOACs) in comparison with standard low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in patients with hematological malignancies. Eligible participants will be randomized…
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for stuffy noses: experimental drug targets nasal polyps
Disease control OngoingThis study will evaluate the effect and safety of 611 in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Heart rhythm breakthrough? new ablation device shows promise for AFib
Disease control CompletedThe objective of this clinical study is to demonstrate that ablation with the TactiFlex SE Ablation catheter, in conjunction with a compatible pulsed field ablation (PFA) and/or radio frequency (RF) generator, is safe and effective for the treatment of symptomatic, recurrent, dru…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Weekly shot could replace daily insulin for thalassemia kids with diabetes
Disease control CompletedBlood transfusion and iron-chelation therapy have prolonged and improved the quality of life in patients with β-thalassemia. The improvement was mainly due to the decrease in mortality from heart failure Such a treatment, however, leads to chronic iron overload and frequently to …
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a drug for eczema soothe the agony of Post-Burn itch?
Symptom relief Recruiting nowThe goal of this study is to test the efficacy of Dupixent in improving post-burn itching symptoms versus the current standard of care.
Phase: PHASE2 • Sponsor: Akron Children's Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 19:19 UTC
-
New liver stent aims to tame deadly cirrhosis complications
Disease control Recruiting nowThis Study is a prospective, multi-center, single-arm objective perform an criteria (OPC) study. A 12 months follow-up study on the patients who intend to receive the treatment of cirrhosis and complications of portal hypertension with the TIPS Stent Graft will be conducted. The …
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug combo aims to shrink mouth cancer before surgery
Disease control Recruiting nowTo learn if giving cemiplimab and cetuximab before salvage surgery can help to control recurrent oral cavity squamous cell carcinoma.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New daily pill hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis is a multi-center, open-label study to investigate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity of REC-1245 administered orally on a once daily (QD) schedule in participants with unresectable, locally advanced, or metastati…
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Lung cancer treatment could get easier: shot may replace IV infusion
Disease control OngoingResearchers are looking for new ways to treat non-small cell lung cancer (NSCLC) that is metastatic, which means cancer has spread to other parts of the body. Some people with metastatic NSCLC are treated with pembrolizumab, an immunotherapy treatment that is given into a vein a…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC